Page last updated: 2024-09-05

deflazacort and osteoprotegerin

deflazacort has been researched along with osteoprotegerin in 2 studies

Compound Research Comparison

Studies (deflazacort)	Trials (deflazacort)	Recent Studies (post-2010) (deflazacort)	Studies (osteoprotegerin)	Trials (osteoprotegerin)	Recent Studies (post-2010) (osteoprotegerin)
452	99	115	5,108	212	2,726

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, KH; Chung, H; Han, IK; Han, KO; Hwang, CS; Jang, HC; Kang, YS; Moon, IK; Yim, CH; Yoon, HK	1
Davie, MW; Humphrey, EL; Marshall, MJ; Williams, JH	1

Other Studies

2 other study(ies) available for deflazacort and osteoprotegerin

Article	Year
Deflazacort increases osteoclast formation in mouse bone marrow culture and the ratio of RANKL/OPG mRNA expression in marrow stromal cells. Journal of Korean medical science, 2001, Volume: 16, Issue:6 Topics: Animals; Bone Marrow Cells; Calcitriol; Calcium Channel Agonists; Carrier Proteins; Cell Differentiation; Cells, Cultured; Dexamethasone; Gene Expression; Glucocorticoids; Glycoproteins; Immunosuppressive Agents; Male; Membrane Glycoproteins; Mice; Mice, Inbred ICR; Osteoclasts; Osteoprotegerin; Pregnenediones; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; RNA, Messenger; Stromal Cells	2001
Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone, 2006, Volume: 38, Issue:5 Topics: Carrier Proteins; Desoximetasone; Dexamethasone; Gene Expression; Glucocorticoids; Glycoproteins; Humans; Hydroxycorticosteroids; Membrane Glycoproteins; Osteoblasts; Osteoprotegerin; Prednisolone; Pregnenediones; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor	2006

Article

Year

Deflazacort increases osteoclast formation in mouse bone marrow culture and the ratio of RANKL/OPG mRNA expression in marrow stromal cells.

Journal of Korean medical science, 2001, Volume: 16, Issue:6

Topics: Animals; Bone Marrow Cells; Calcitriol; Calcium Channel Agonists; Carrier Proteins; Cell Differentiation; Cells, Cultured; Dexamethasone; Gene Expression; Glucocorticoids; Glycoproteins; Immunosuppressive Agents; Male; Membrane Glycoproteins; Mice; Mice, Inbred ICR; Osteoclasts; Osteoprotegerin; Pregnenediones; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; RNA, Messenger; Stromal Cells

2001

Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.

Bone, 2006, Volume: 38, Issue:5

Topics: Carrier Proteins; Desoximetasone; Dexamethasone; Gene Expression; Glucocorticoids; Glycoproteins; Humans; Hydroxycorticosteroids; Membrane Glycoproteins; Osteoblasts; Osteoprotegerin; Prednisolone; Pregnenediones; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor

2006